BioSpace News Archive

Aneurysm Coiling Market Trends, On-going Demand, Opportunities, Segmentation, and Forecast till 2031

Wilmington, Delaware, United States, Transparency Market Research Inc. – Atherosclerosis is the thickening, hardening, and loss of elasticity of the walls of the arteries.

August 30, 2022
·
6 min read
Disease-Modifying Antirheumatic Drug (DMARD) Market is Driven by Rising Prevalence of Arthritis

Wilmington, Delaware, United States, Transparency Market Research Inc. – Disease-modifying antirheumatic drugs (DMARDs) are a class of drugs utilized as a therapy for inflammatory arthritis, including psoriatic arthritis (PsA), rheumatoid arthritis (RA), and ankylosing spondylitis (AS).

August 30, 2022
·
6 min read
Dysmenorrhea Treatment Market: Increase in Government Awareness Campaigns About Women’s Health to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – Dysmenorrhea is a medical term for the pain females experience during menstrual cycle

August 30, 2022
·
5 min read
Drug Development

AMGEN ANNOUNCES TOPLINE DATA FROM LUMAKRAS® (SOTORASIB) PHASE 3 TRIAL IN NON-SMALL CELL LUNG CANCER

Amgen (NASDAQ: AMGN) today announced that the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS® (sotorasib) met its primary endpoint of progression-free survival (PFS), demonstrating statistical significance and superiority over standard of care chemotherapy, intravenous docetaxel.

August 30, 2022
·
16 min read
Biotech Bay

Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Spruce Biosciences, Inc. (Nasdaq: SPRB), today announced that Samir Gharib, President and Chief Financial Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022 at 5:00 pm ET.

August 30, 2022
·
1 min read
BioMidwest

ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference.

August 30, 2022
·
1 min read
Biotech Bay

Invitae to Present at Upcoming Investor Conference in September 2022

Invitae, a leading medical genetics company, announced that members of its management team will participate in the following investor conference.

August 30, 2022
·
1 min read
Biotech Bay

Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Morgan Stanley 20th Annual Global Healthcare Conference held in New York, New York.

August 30, 2022
·
1 min read
Biotech Beach

Oncocyte Announces Five-Year VA Contract for DetermaRx

Oncocyte Corporation announced that the US Department of Veterans Affairs, the largest integrated health care system in the United States, has awarded a Federal Supply Schedule Contract for the Company’s DetermaRx™ test.

August 30, 2022
·
4 min read
Clinical Chemistry Analyzers Market of ~US$ 16.3 Bn by 2030

The global clinical chemistry analyzers market was valued at ~US$ 11.3 Bn in 2021. The clinical chemistry analyzers market is projected to expand at a CAGR of ~4% from 2022 to 2030.

August 30, 2022
·
10 min read